Technical Analysis for ALVR - AlloVir, Inc.

Grade Last Price % Change Price Change
D 6.04 -5.63% -0.36
ALVR closed down 5.63 percent on Wednesday, February 8, 2023, on 73 percent of normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Down

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish 0.00%
Earnings Movers Other 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Bearish Engulfing Bearish -5.63%
Upper Bollinger Band Walk Strength -5.63%
Wide Bands Range Expansion -5.63%
Overbought Stochastic Strength -5.63%
Down 3 Days in a Row Weakness -5.63%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 5% about 9 hours ago
Fell Below 10 DMA about 9 hours ago
10 DMA Support about 10 hours ago
200 DMA Support about 10 hours ago
Fell Below 200 DMA about 10 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

AlloVir is a leading late clinical-stage cell therapy company with a focus on restoring natural immunity against life-threatening viral diseases in patients with severely weakened immune systems. The company’s innovative and proprietary technology platforms leverage off-the-shelf, allogeneic, multi-virus specific T cells targeting devastating viruses for patients with T cell deficiencies who are at risk from the life-threatening consequences of viral diseases. AlloVir’s technology and manufacturing process enables the potential for the treatment and prevention of a spectrum of devastating viruses with each single allogeneic cell therapy. The company is advancing multiple mid- and late-stage clinical trials across its product portfolio.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Immune System Stem Cell Gene Therapy Cell Biology Cell Therapy Manufacturing Process Proprietary Technology Viruses Viral Disease Virus Immunity Zoonoses Shimon Slavin Covid 19

Is ALVR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 10.29
52 Week Low 3.17
Average Volume 230,875
200-Day Moving Average 6.19
50-Day Moving Average 6.00
20-Day Moving Average 5.78
10-Day Moving Average 6.12
Average True Range 0.42
RSI 52.15
ADX 20.55
+DI 28.14
-DI 17.43
Chandelier Exit (Long, 3 ATRs) 5.70
Chandelier Exit (Short, 3 ATRs) 6.21
Upper Bollinger Bands 6.69
Lower Bollinger Band 4.88
Percent B (%b) 0.64
BandWidth 31.15
MACD Line 0.14
MACD Signal Line 0.03
MACD Histogram 0.1097
Fundamentals Value
Market Cap 372.42 Million
Num Shares 61.7 Million
EPS
Price-to-Sales 0.00
Price-to-Book 7.27
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.61
Resistance 3 (R3) 6.67 6.55 6.52
Resistance 2 (R2) 6.55 6.40 6.52 6.48
Resistance 1 (R1) 6.29 6.31 6.23 6.23 6.45
Pivot Point 6.17 6.17 6.14 6.14 6.17
Support 1 (S1) 5.91 6.02 5.85 5.85 5.63
Support 2 (S2) 5.79 5.93 5.76 5.60
Support 3 (S3) 5.53 5.79 5.57
Support 4 (S4) 5.47